What’s the game plan of life sciences VC fund floated by Actis-owned firm's execs?
Advertisement

What’s the game plan of life sciences VC fund floated by Actis-owned firm's execs?

By Sreeja Biswas

  • 17 Dec 2024
Premium
What’s the game plan of life sciences VC fund floated by Actis-owned firm's execs?
Jasmeet Chhabra (left) and Vishal Goel, Innovation Acceleration Platform (IXP)

Three current and former executives of Rx Propellant, a life sciences-focused infrastructure provider owned by private equity firm Actis, have come together to float a venture capital fund to bet on biotech startups.  Vishal Goel and Jasmeet Chhabra, who have been engaged in real estate investments for nearly two decades, have ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News